The positive expression of HER2 was related to tumor type, tumor size, degree of differentiation, and lymph node metastasis, indicating that the overexpression of HER2 may play important role in advanced NSCLC events. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.